These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31432354)

  • 1. Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event.
    Türkoğlu R; Benbir G; Özyurt S; Arsoy E; Akbayır E; Turan S; Karadeniz D; Yılmaz V; Gencer M; Tüzün E
    Int Ophthalmol; 2020 Jan; 40(1):151-158. PubMed ID: 31432354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation.
    Düzel B; Tamam Y; Çoban A; Tüzün E
    Immunol Invest; 2019 Feb; 48(2):190-197. PubMed ID: 30321074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective sleep quality and daytime sleepiness in late midlife and their association with age-related changes in cognition.
    Waller KL; Mortensen EL; Avlund K; Osler M; Fagerlund B; Lauritzen M; Jennum P
    Sleep Med; 2016 Jan; 17():165-73. PubMed ID: 26188599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Performance of Patients With Multiple Sclerosis and Optic Neuritis at Presentation.
    Leshno A; Sagiv O; Aloni R; Skaat A; Achiron A; Huna-Baron R
    J Neuroophthalmol; 2022 Mar; 42(1):e8-e13. PubMed ID: 33870943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
    Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study.
    Nociti V; Losavio FA; Gnoni V; Losurdo A; Testani E; Vollono C; Frisullo G; Brunetti V; Mirabella M; Della Marca G
    J Neurol Sci; 2017 Jan; 372():387-392. PubMed ID: 27823835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.
    Optic Neuritis Study Group
    Arch Neurol; 2008 Jun; 65(6):727-32. PubMed ID: 18541792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute demyelinating optic neuritis.
    Foroozan R; Buono LM; Savino PJ; Sergott RC
    Curr Opin Ophthalmol; 2002 Dec; 13(6):375-80. PubMed ID: 12441840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of optic neuritis and multiple sclerosis.
    Van Stavern GP
    Curr Opin Ophthalmol; 2001 Dec; 12(6):400-7. PubMed ID: 11734679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
    Felgueiras H; Parra J; Cruz S; Pereira P; Santos AF; Rua A; Meira D; Fonseca P; Pedrosa C; Cardoso JN; Almeida C; Araújo M; Santos E
    J Neuroophthalmol; 2016 Sep; 36(3):275-9. PubMed ID: 27261948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
    Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
    Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts of the pathogenesis of optic neuritis associated with multiple sclerosis.
    Sergott RC; Brown MJ
    Surv Ophthalmol; 1988; 33(2):108-16. PubMed ID: 3055389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis.
    Compston DA; Batchelor JR; Earl CJ; McDonald WI
    Brain; 1978 Sep; 101(3):495-511. PubMed ID: 709354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
    Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep quality and daytime sleepiness are not associated with cognition in heart failure.
    Walter FA; Ede D; Hawkins MAW; Dolansky MA; Gunstad J; Josephson R; Moore SM; Hughes JW
    J Psychosom Res; 2018 Oct; 113():100-106. PubMed ID: 30190041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.
    Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up.
    Francis DA; Compston DA; Batchelor JR; McDonald WI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):758-65. PubMed ID: 3497228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep disturbance and memory dysfunction in early multiple sclerosis.
    Sumowski JF; Horng S; Brandstadter R; Krieger S; Leavitt VM; Katz Sand I; Fabian M; Klineova S; Graney R; Riley CS; Lublin FD; Miller AE; Varga AW
    Ann Clin Transl Neurol; 2021 Jun; 8(6):1172-1182. PubMed ID: 33951348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
    Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H
    Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.